Veradigm Inc. (MDRX) - Total Assets
Based on the latest financial reports, Veradigm Inc. (MDRX) holds total assets worth $1.69 Billion USD as of September 2022. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Veradigm Inc. (MDRX) shareholders funds for net asset value and shareholders' equity analysis.
Veradigm Inc. - Total Assets Trend (1998–2024)
This chart illustrates how Veradigm Inc.'s total assets have evolved over time, based on quarterly financial data.
Veradigm Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Veradigm Inc.'s total assets of $1.69 Billion consist of 45.2% current assets and 54.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 29.7% |
| Accounts Receivable | $175.72 Million | 11.7% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $164.41 Million | 10.9% |
| Goodwill | $532.64 Million | 35.4% |
Asset Composition Trend (1998–2024)
This chart illustrates how Veradigm Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Veradigm Inc. worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Veradigm Inc.'s current assets represent 45.2% of total assets in 2024, a decrease from 70.9% in 1998.
- Cash Position: Cash and equivalents constituted 29.7% of total assets in 2024, up from 3.7% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 45.0% of total assets, an increase from 19.0% in 1998.
- Asset Diversification: The largest asset category is goodwill at 35.4% of total assets.
Veradigm Inc. Competitors by Total Assets
Key competitors of Veradigm Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
VSee Health, Inc.
NASDAQ:VSEE
|
USA | $18.71 Million |
|
Oakridge International Ltd
AU:OAK
|
Australia | AU$1.61 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$23.68 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
|
Alcidion Group Ltd
AU:ALC
|
Australia | AU$115.63 Million |
|
Oneview Healthcare Plc
AU:ONE
|
Australia | AU$15.49 Million |
Veradigm Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.20 | 1.42 | 0.99 |
| Quick Ratio | 3.20 | 1.39 | 0.99 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $557.68 Million | $238.02 Million | $-11.19 Million |
Veradigm Inc. - Advanced Valuation Insights
This section examines the relationship between Veradigm Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.48 |
| Latest Market Cap to Assets Ratio | 0.35 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | $1.50 Billion |
| Market Capitalization | $528.16 Million USD |
Valuation Analysis
Below Book Valuation: The market values Veradigm Inc.'s assets below their book value (0.35x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Veradigm Inc.'s assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Veradigm Inc. (1998–2024)
The table below shows the annual total assets of Veradigm Inc. from 1998 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $1.50 Billion | 0.00% |
| 2022-12-31 | $1.50 Billion | -37.96% |
| 2021-12-31 | $2.43 Billion | -16.88% |
| 2020-12-31 | $2.92 Billion | -8.99% |
| 2019-12-31 | $3.21 Billion | +0.76% |
| 2018-12-31 | $3.18 Billion | -24.79% |
| 2017-12-31 | $4.23 Billion | +10.39% |
| 2016-12-31 | $3.83 Billion | +42.89% |
| 2015-12-31 | $2.68 Billion | +8.83% |
| 2014-12-31 | $2.46 Billion | -5.93% |
| 2013-12-31 | $2.62 Billion | +11.50% |
| 2012-12-31 | $2.35 Billion | -6.67% |
| 2011-12-31 | $2.52 Billion | +4.08% |
| 2010-12-31 | $2.42 Billion | +153.87% |
| 2009-12-31 | $952.70 Million | +0.00% |
| 2008-12-31 | $952.66 Million | 0.00% |
| 2007-12-31 | $952.66 Million | +99.46% |
| 2006-12-31 | $477.61 Million | +116.15% |
| 2005-12-31 | $220.96 Million | +13.80% |
| 2004-12-31 | $194.18 Million | +75.90% |
| 2003-12-31 | $110.39 Million | +5.79% |
| 2002-12-31 | $104.35 Million | -11.15% |
| 2001-12-31 | $117.44 Million | -61.55% |
| 2000-12-31 | $305.42 Million | +312.65% |
| 1999-12-31 | $74.01 Million | +291.61% |
| 1998-12-31 | $18.90 Million | -- |
About Veradigm Inc.
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle se… Read more